Mars

Mars Licenses Pairwise’s Fulcrum® Gene Editing Platform

Pairwise has closed a $40 million Series C funding round, led by Deerfield Management, with new investment from Corteva Inc., along with returning investors Aliment Capital and Leaps by Bayer.

Read More